DrugPatentWatch Database Preview
Journey Company Profile
Email this page to a colleague
» See Plans and PricingWhat is the competitive landscape for JOURNEY, and what generic alternatives to JOURNEY drugs are available?
JOURNEY has three approved drugs.
There are six US patents protecting JOURNEY drugs.
There are thirteen patent family members on JOURNEY drugs in ten countries.
Summary for Journey
| International Patents: | 13 |
| US Patents: | 6 |
| Tradenames: | 2 |
| Ingredients: | 2 |
| NDAs: | 3 |
| Patent Litigation for Journey: | See patent lawsuits for Journey |
Drugs and US Patents for Journey
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Journey | XIMINO | minocycline hydrochloride | CAPSULE, EXTENDED RELEASE;ORAL | 201922-005 | Jul 11, 2012 | RX | No | No | 8,252,776 | Start Trial | Start Trial | ||||
| Journey | XIMINO | minocycline hydrochloride | CAPSULE, EXTENDED RELEASE;ORAL | 201922-003 | Jul 11, 2012 | RX | No | No | 7,541,347 | Start Trial | Start Trial | ||||
| Journey | XIMINO | minocycline hydrochloride | CAPSULE, EXTENDED RELEASE;ORAL | 201922-001 | Jul 11, 2012 | RX | No | No | 7,541,347 | Start Trial | Start Trial | ||||
| Journey | XIMINO | minocycline hydrochloride | CAPSULE, EXTENDED RELEASE;ORAL | 201922-005 | Jul 11, 2012 | RX | No | No | 7,541,347 | Start Trial | Start Trial | ||||
| Journey | XIMINO | minocycline hydrochloride | CAPSULE, EXTENDED RELEASE;ORAL | 201922-002 | Jul 11, 2012 | DISCN | No | No | Start Trial | Start Trial | |||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for Journey
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Journey | XIMINO | minocycline hydrochloride | CAPSULE, EXTENDED RELEASE;ORAL | 201922-001 | Jul 11, 2012 | 5,908,838 | Start Trial |
| Journey | EXELDERM | sulconazole nitrate | SOLUTION;TOPICAL | 018738-001 | Aug 30, 1985 | 4,055,652 | Start Trial |
| Journey | XIMINO | minocycline hydrochloride | CAPSULE, EXTENDED RELEASE;ORAL | 201922-003 | Jul 11, 2012 | 5,908,838 | Start Trial |
| Journey | XIMINO | minocycline hydrochloride | CAPSULE, EXTENDED RELEASE;ORAL | 201922-005 | Jul 11, 2012 | 5,908,838 | Start Trial |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for Journey Drugs
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| Israel | 188331 | Start Trial |
| Australia | 2006262428 | Start Trial |
| New Zealand | 564093 | Start Trial |
| World Intellectual Property Organization (WIPO) | 2007001961 | Start Trial |
| China | 101208097 | Start Trial |
| >Country | >Patent Number | >Estimated Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
